2. Academic Validation
  3. 6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin- 2-ones: a novel class of potent, selective, and orally active nonsteroidal progesterone receptor antagonists

6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin- 2-ones: a novel class of potent, selective, and orally active nonsteroidal progesterone receptor antagonists

  • J Med Chem. 2002 Sep 26;45(20):4379-82. doi: 10.1021/jm025555e.
Puwen Zhang 1,  Eugene A Terefenko,  Andrew Fensome,  Jay Wrobel,  Richard Winneker,  Scott Lundeen,  Keith B Marschke,  Zhiming Zhang
Affiliations

Affiliation

  • 1 Chemical Sciences, Women's Health Research Institute, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, USA. Zhangp@wyeth.com
PMID: 12238914 DOI: 10.1021/jm025555e
Abstract

Novel 6-aryl-1,4-dihydro-benzo[d][1,3]oxazin-2-ones were synthesized and tested as Progesterone Receptor (PR) antagonists. These compounds were potent and showed good selectivity for PR over Other steroid receptors such as the glucocorticoid and androgen receptors (e.g., greater than 80-fold selectivity at PR for 4h). Numerous 6-aryl benzoxazinones (e.g., 4h-j) were active orally in the uterine decidualization and component C3 assays in the rats. In these in vivo models,4h had potencies comparable to mifepristone.

Figures